Unless you are Rip Van Winkle and have been asleep the past 5 years, you likely have noticed that corporations are calling more frequently now than ever before to buy your practice. Corporate consolidation has reached a point of inevitability
As we described in a prior Practice Edge article, the drug manufacturer world has consolidated significantly in the last 10-15 years, going from 15+ manufacturers
And then there were four. When Boehringer-Ingelheim bought Merial in early 2017, the veterinary drug manufacturers consolidated to four major players – BI, Zoetis, Elanco
Veterinary Study Groups (VSG), a leading provider of management support for practices in the United States and Canada and Veterinary Practice Partners (VPP), the co-owner
Take a peek behind the curtain as we investigate the determining factors behind a practice’s valuation. VPP reveals what investors look for in a practice, and discuss how to raise your valuation over time so you get the most value when you’re ready to sell.
